Browse DSHEA Content

Last week, CHPA, the American Herbal Products Association, the Council for Responsible Nutrition, and the United Natural Products Alliance sent a letter to Senators Tammy Baldwin (D-Wisc.) and John Hoeven (R-N.D.), the Chair and Ranking Member of the Appropriations Subcommittee that has jurisdiction over FDA funding, highlighting the need for additional resources for the Office of Dietary Supplement Programs at FDA due to the growing dietary supplement market.

Jun 10, 2021

CHPA released the following statement in response to new research published in Clinical Toxicology. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements.

Mar 23, 2021

For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.

Jan 7, 2021

CHPA released the following statement in response to FDA’s warning that consumers avoid certain male enhancement and weight loss products sold by major online retailers due to hidden, potentially dangerous drug ingredients.

Dec 18, 2020

Today’s column in the Los Angeles Times is aligned with calls from responsible manufacturers in the dietary supplement industry who agree that regulations need to be modernized and strengthened.

Dec 15, 2020

CHPA submitted comments this week to the Food and Drug Administration regarding the proposed development of an authorized list of dietary ingredients marketed prior to the Dietary Supplement Health and Education Act.

Dec 7, 2017

Here CHPA provides feedback on FDA's proposed development of an authorized list of pre-Dietary Supplement Health and Education Act (DSHEA) dietary ingredients.

Dec 4, 2017

Scientific experts familiar with herbal products and their testing methods maintain that the DNA barcode test is not an appropriate method to determine what is in an herbal dietary supplement.

Feb 23, 2015

Echoing earlier comments submitted to the agency, CHPA and its member companies marketing dietary supplement products support the presumption of safety for dietary ingredients outlined in the 1994 passage of DSHEA.

Oct 24, 2013

The industry favors and supports the development of reasonable guidance. However, the agency’s attempt to redefine the NDI notification process contradicts the letter and spirit of DSHEA. The Draft Guidance would undo nearly two decades of agency practice and policy.

Dec 2, 2011

Filter Results